UK markets closed

BioXcel Therapeutics, Inc. (BTAI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.5945+0.0245 (+0.95%)
As of 09:31AM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts6666
Avg. Estimate-0.7-0.71-2.66-1.83
Low estimate-0.82-0.89-3.19-2.9
High estimate-0.56-0.57-2.16-0.89
Year ago EPS-1.84-1.83-6.15-2.66
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts5555
Avg. Estimate460k590k2.76M9.67M
Low estimate400k450k2.03M7.4M
High estimate500k750k3.5M11.6M
Year ago sales206k457k1.38M2.76M
Sales growth (year/est)123.30%29.10%100.00%250.40%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-1.62-1.75-1.3-0.91
Actual EPS-1.84-1.83-1.72-0.76
Difference-0.22-0.08-0.420.15
Surprise %-13.60%-4.60%-32.30%16.50%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.7-0.71-2.66-1.83
7 days ago-0.7-0.71-2.66-1.83
30 days ago-0.78-0.75-2.78-2.06
60 days ago-0.97-0.85-2.47-1.67
90 days ago-1.02-0.89-2.51-1.77
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days2332
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/A11
Growth estimatesBTAIIndustrySector(s)S&P 500
Current qtr.62.00%N/AN/AN/A
Next qtr.61.20%N/AN/AN/A
Current year56.70%N/AN/AN/A
Next year31.20%N/AN/AN/A
Next 5 years (per annum)294.10%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A